During the past 10 years, dr. Kuijper and members of his group obtained various grants from national and European organizations for scientific and clinical research on the area of C. difficile infections and infections with antibiotic resistant bacteria. In 2017, he developed the 'Microbiota Platform in LUMC' with many collaborations within and outside LUMC. He has more than 400 publications in peer reviewed journals and chapters in books. Between 2009 and 2016, dr. E.J. Kuijper has been president of the European Study Group on Clostridium difficile (ESCGD), which has been co-opted by the European Society of Clinical Microbiology and Infectious Diseases (ESCMID). Currently, he leads an new European Study group 'Host-microbiota interactions in human and animal medicine'.